Myeloma and lymphoma Flashcards

1
Q

where does the first stage of B cell differentiation take place

A

bone marrow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what happens to B cells in the first stage of differentiation.

A

pro B cells form naïve B cells.
gain surface immunoglobulins
each B cell is committed to a single light chain (kappa or lambda)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are 2 light chains in B cell called

A

kappa and lambda.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

the first stage of B cell differentiation is also known as

A

antigen independent stage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

where does the second stage of B cell differentiation take place.

A

inside the lymph organs- lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the second stage of B cell differentiation also known as

A

antigen dependent stage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what happens in the second stage of cell differentiation

A

Mature naïve B cells develop into proliferating blast cells after encountering an antigen or T cell activation, and here they apoptose, become short-lived plasma cells or enter the germinal centre.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

where does somatic hypermutation and heavy class switching occur

A

germinal centre in response to antigen presentation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The process by which naïve B-cell blasts become either plasma or memory B-cells involve four steps which are

A
proliferation
immunoglobulin somatic hypermutation and class switching, selection and differentiation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what protein is needed to form plasma blasts

A

NF-kB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what B cells which undergo somatic hypermutations are known as

A

centrocytes/ centroblasts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

define somatic hypermutation

A

A process by which the Mature B cells undergo mutation making them more or less specific to the antigen which they were presented with.
If the mutation is not favourable the cell will undergo apoptosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what molecule are immunoglobulins made up of

A

glycoprotein.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

immunoglobulins are composed of how many polypeptide chains

A

two “light chains” and two “heavy chains”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what tip of bond holds the light and heavy chains of an immunoglobulin together

A

covalent disulphide bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the 5 main types of heavy chains

A

IgG, IgM, IgA, IgD, IgE-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

define protein electrophoresis

A

laboratory technique whereby serum is placed in a gel and exposed to an electric current

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what 5 major fractions are shown on a normal antibody electrophorus

A
Serum albumin
Alpha-1 globulins
Alpha-2 globulins
Beta glogulins
Gamma globulins- flat hump, with no peaks as all the immunoglobulin’s are produced in equal amounts.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When is immunofixation used

A

after the protein electrophoresis comes back with a M peak.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what does a immunofixation show

A

Enables the detection and identification of monoclonal immunoglobulins

21
Q

define myeloma

A

incurable malignancy of plasma cells.

22
Q

what form do all myelomas originate at

A

MGUS- monoclonal gammopathy of uncertain significance- abnormal spike on protein electrophoresis up asymptomatic.

23
Q

what organ is commonly affected in myeloma

A

kidney

MGRS- monoclonal gammopathy of renal significance- so has renal dysfunction

24
Q

define solitary plasmacytoma

A

group of plasma cells deposit e.g. in femur., not much myeloma in the bone marrow.

25
Q

what is the name given to the worst form of myeloma

A

plasma cell leukaemia- full-blown myeloma with severe symptoms

26
Q

what is the diagnostic criteria for myeloma.

A

Clonal BM plasma cells >10%( more than 10% neoplastic plasma cells in bone marrow) or biopsy-proven bony or extramedullary plasmacytoma AND any one or more of:
CRAB features
MDEs

27
Q

what are CRAB features

A

– C- hypercalcemia (177 micrimol/L.

– A- anaemia Hb

28
Q

what are the myeloma defining events.

A

– > 60% clonal plasma cells on BM biopsy
– SFLC (serum free light chain) ratio >100mg/L provided the absolute level of the involved LC is >100mg/L
– Light chains clog up the kidney.
– >1 focal lesion on MRI measuring >5mm

29
Q

how is initial management of acute kidney injury with suspected myeloma carried out.
(what investigations need to be carried out)

A
  • Blood film
  • Electrophoresis
  • Immunofixation
  • Bone marrow biopsy with
  • flow cytometry
  • start on steroids- even before diagnosis.
30
Q

what intensive therapy is provided for patients with myeloma

A

VCD-chemotherpay (given in 4 cyclic whilst you harvest patient stem cell)
GCSF- injections which helps spill stem cells form the bone marrow in t peripheral blood.
Melphalan-big chemotherapy dose resulting in neutropenia, reduced RBC and platelets and then they patient is regiven their stem cells to help them recover.

31
Q

what is the function of treatment with GCSF

A

spill stem cells form the bone marrow in t peripheral blood.

32
Q

what are the negative consequences of melphalan chemotherapy

A

neutropenia, reduced RBC and platelets

33
Q

newer drugs from the treatment of myeoma

A

Daratumumab (antiCD138)
Carfilzomib (proteosome inhibitor)
Ixazomib (proteosome inhibitor)

34
Q

what is the non-intensive therapy that is used to treat myeloma

A
  • CDTa- given initially (a= attenuated)= attenuated chemotherapy.
  • VCD- given next in small dose= aim of treatment is to prevent complications such as bone injury not cure.
  • RD (oral chemotherapy)= given after CDTa and VCD until disease progression.
35
Q

In what groups of people are non-invasive treatment for myeloma typically provided

A

elderly, immunocompromised.

36
Q

what is the initial treatment given all all patients who have suspected myeloma even if it hasn’t yet been confirmed

A

steroids

37
Q

what are patients in remission treated with

A

oral chemotherapy- RD

38
Q

what is the future of treatment of monoclonal antibodies

A

Targeted therapies
Individualised therapy
monoclonal antibodies

39
Q

what condition is commonly associated with myeloma

A

AL amyloidosis

40
Q

define AL amyloidosis

A

Amyloid light chain amyloidosis.
Neoplastic plasma cells secrete abnormal proteins which misfold and then accumulate in organs causing them to enlarge.
Light chain fragments misfold and self-aggregate to form beta-pleated fibrils

41
Q

what are the complications of AL amyloidosis

A
Nephrotic-range proteinuria:
Mainly albumin
Small monoclonal light chain component
Cardiac and liver involvement in 30%
Peripheral neuropathy in 10%
end stage renal failure
42
Q

how does follicular lymphoma commonly present

A

painful lump in eck

43
Q

define follicular lymphoma

A

neoplastic disorder of lymphoid tissue.

44
Q

how do you acquire follicular lymphoma

A

chromosomal translocation – t(14;18) – which brings the bcl2 protooncogene under the influence of the immunoglobulin heavy-chain gene leading to over-expression of the bcl-2 protein.

45
Q

if follicular lymphoma equally present in both genders

A

yes

46
Q

Follicular International Prognostic Index (FLIPI) can be used to prognosticate lymphoma:

A
  • age >60 years
  • LDH above the limit of normal at diagnosis.
  • Hb
47
Q

is follicular lymphoma a hodgkin or non hodgkin lymphoma

A

non- hodgkin lymphoma

48
Q

In AL amyloidosis the light chains misfiled into what.

A

Light chain fragments misfold and self-aggregate to form beta-pleated fibrils